Hers Menopause Alternatives: 8 Options Compared, and How to Switch Without Losing Your Prescription
Match the replacement to the gap
Use the free matching tool to filter by symptoms, age, state, insurance, uterus status, medication route, and when online care is not the right starting point.
The best Hers menopause alternatives are Midi Health for insurance-based care, Alloy for transparent cash pricing, Wisp for a one-time care fee and local pharmacy, and Winona for medication shipped without a 12-month price condition. Hers can still be the better value when your current regimen works. State, age, insurance, and medication form decide the answer.
Best for: women comparing a real replacement for Hers because of insurance, billing cadence, state access, medication form, pharmacy control, or the July 2026 FTC lawsuit.
Not for you if: you are deciding whether to start, stop, or change hormone therapy; need an examination; have unexplained bleeding after menopause; are outside the United States; or meant nonhormonal alternatives to hormone therapy.
| Your deciding issue | Best starting path | Key number or limit | What to verify before paying |
|---|---|---|---|
| Insurance should help pay | Midi Health or Evernow pay-per-visit | Midi: $250 initial / $150 follow-up self-pay; Evernow: $150 self-pay visit | Network status, deductible, exact drug coverage, pharmacy network |
| One shipped price with medication included | Alloy, Winona, or Hers | Alloy pill + progesterone: $804.88 first year at published entry prices | Exact dose, first charge, renewal date, cancellation cutoff |
| Local pharmacy and no long plan | Wisp | $99 for consult, follow-ups, and 3 months of care-team access; medication extra | Drug price at your pharmacy and what happens after month 3 |
| Month-to-month or pay-per-visit care | Evernow | $49 month-to-month membership or $150 self-pay visit | Whether the visit, membership, and medication are three separate charges |
| Compounded all-in-one vaginal cream | Inner Balance Oestra | $199/month for 6 months, then $99.50/month | Compounded status, dispensing pharmacy, route-specific evidence, dose-adjustment fees |
Here is the part almost nobody tells you: leaving Hers can cost more, not less. Hers publishes oral medication from $79 a month and patches from $134 a month, both with a 12-month plan. At those published entry prices, oral care is $948 over 12 months. Winona’s patch plus progesterone entry-price path is $2,444 over thirteen 28-day cycles.
So this page treats Hers as the benchmark, not the villain. We show what each alternative fixes, what it costs, who it excludes, whether the medication is FDA-approved or compounded, and how to move without letting your prescription disappear between providers.
One more thing belongs above the fold because it may be why you searched: on July 29, 2026, the Federal Trade Commission, California through Los Angeles County Counsel, and Utah sued Hims & Hers Health, Inc. The pending complaint alleges deceptive subscription billing, difficult cancellation, and sharing sensitive health information with advertising platforms. Hims & Hers denies the allegations. No court has ruled.
The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.
What did The HRT Index actually verify?
Answer: On August 13, 2026, we checked the live pricing, insurance, state, age, medication, lab, pharmacy, billing, cancellation, and regulatory pages used in this comparison. We also read the FTC case page and filed complaint, not just news coverage. We did not enroll, complete checkout, receive medication, or test cancellation ourselves.
The HRT Index Verification Standard: read every published price; separate FDA-approved products from compounded products at the product level; verify state availability and insurance; and re-check top providers monthly and the full roster quarterly. Where intake, dose, plan, insurance, or checkout controls the answer, this page says confirm at checkout instead of inventing a number.
The source hierarchy is simple:
- Verified on a primary source means the provider, FDA, FTC, federal regulation, The Menopause Society, ACOG, or a cited peer-reviewed paper published the fact.
- Provider-stated means the company states it, but the claim depends on the exact product or checkout result.
- Published conflict means the company’s own pages do not agree. We show the conflict instead of quietly choosing the friendlier version.
- Confirm at checkout means your state, dose, pharmacy, plan, or clinical intake determines the answer.
The right online HRT provider is not the same for every woman—it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer cannot resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider—and to flag when online care is not the right starting point—before your first consult.
Match my situation before I pay →
Hers menopause alternatives: which one fixes your reason for leaving?
Answer: The best alternative depends on the failure you are trying to remove. Midi fixes insurance and broad clinical access; Wisp fixes long-plan commitment and gives you a local-pharmacy prescription; Alloy fixes price opacity with product-by-product cash pricing; Winona preserves shipped medication; and Evernow gives you membership or pay-per-visit care in every state plus D.C.
Find your row. Skip the rest of the page if it resolves the decision.
| Why you are looking | Best fit | What it fixes | The catch |
|---|---|---|---|
| I need commercial insurance to help pay for the visit | Midi Health or Evernow | Insurance-eligible visits and local-pharmacy fulfillment | Verify network, deductible, formulary, and pharmacy separately |
| I want one shipped price with medication included | Alloy or Winona | Product pricing is published; medications can ship | Entry prices can change with dose; Winona is limited to ages 35–59 and 37 states plus Puerto Rico |
| I want video care and basic labs when necessary | Sesame | $59/month, video visits, provider choice, basic labs when ordered | Medication is not included; confirm any separate lab charge at booking |
| I want a local pharmacy and a one-time care charge | Wisp | $99 includes consult, follow-ups, and three months of care-team access | Medication is separate; public page does not promise included lab work |
| I want a one-time consult or second opinion | Evernow pay-per-visit | $150 self-pay visit or insurance-eligible video visit | Medication is separate; 90-day portal access follows the visit |
| I am 60 or older | Midi or Evernow | Neither publishes Winona’s 59-year ceiling | Clinical eligibility still depends on history; no telehealth company can promise treatment |
| I need Medicaid or Medi-Cal to pay | Start with your plan or an in-person clinician | These programs can direct you to covered care | Midi specifically cannot treat Medicaid or Medi-Cal patients even as self-pay patients |
| I specifically want a compounded combined cream | Inner Balance Oestra | One compounded vaginal cream combines estradiol and progesterone | The final compounded drug is not FDA-approved and is not a dose-for-dose replacement for an approved patch or pill |
| I want the lowest drug price through my own prescriber | Your clinician + your pharmacy | Removes the telehealth care bundle if you already have a prescriber | Visit access, follow-up, and prescription continuity are now your responsibility |
Check which paths fit my state, insurance, age, and medication form →
Before you switch: Hers might not be the problem
Answer: Hers can remain the right choice when your medication is working, delivery is reliable, and the total charge matches what you agreed to. Its published oral entry price is $948 over 12 months—less than several shipped or clinician-led alternatives. If your real problem is control, document the billing and privacy settings before replacing a regimen that works.
We want to be straight with you, because a page that can only say “leave” is not a comparison. It is a redirect.
Hers publishes oral menopause medication from $79 a month and patches from $134 a month, both with a 12-month plan. Those are entry prices, not a promise that every dose or treatment combination will cost the same. The price includes more than the pharmacy ingredient: online intake, provider review, ongoing messaging, treatment adjustments when appropriate, fulfillment, and shipping.
The comparison that matters is not “$79 versus the cheapest coupon I found.” It is:
- What is charged today?
- How long is the plan?
- What medication and dose are included?
- What care continues after the first prescription?
- Can you use insurance or your own pharmacy?
- What happens to refills when you cancel?
If you already have a clinician willing to prescribe and monitor you, a retail pharmacy may be cheaper. If you came to telehealth because you could not get that appointment, the care layer is not imaginary. It is the thing you are buying.
The reasons to leave that survive the arithmetic are insurance, eligibility, medication form, pharmacy control, and billing commitment. The FTC lawsuit adds a legitimate trust question. None of those requires pretending Hers has no value.
Why do women leave Hers menopause care?
Answer: The verified reasons are the 12-month condition attached to advertised entry prices, no insurance billing for the Hers program, an unpublished state list, a limited published formulary, local-pharmacy restrictions, and the pending FTC lawsuit over billing, cancellation, and health-data practices. Each reason points to a different replacement; there is no universal winner.
| # | Reason | What we verified on August 13, 2026 | Path that clears it |
|---|---|---|---|
| 1 | Advertised entry price is tied to a 12-month plan | Hers publishes oral medication from $79/month and patches from $134/month, both with a 12-month plan | Wisp one-time consult; Midi per visit; Evernow pay-per-visit or month-to-month; Sesame monthly |
| 2 | The monthly figure may not equal today’s charge | Hers says it offers multiple subscription models and price points; current terms allow recurring subscriptions and require cancellation before renewal processing | Write down monthly equivalent, plan length, amount due today, and renewal date before submitting payment |
| 3 | Hers does not bill insurance for the menopause program | Hers markets the program as access without insurance | Midi or Evernow for insurance-eligible visits; Sesame, Wisp, and Alloy can send prescriptions to a pharmacy in models where drug coverage may apply |
| 4 | Hers publishes no complete menopause state list | Hers says the service is not available in every state but does not publish the full list on the checked menopause pages | Midi, Wisp, and Evernow publish nationwide availability; Winona publishes its exact state list |
| 5 | The public kit does not list every route | Hers lists estradiol pill or patch, progesterone pill, and estradiol vaginal cream | Alloy publishes gel and spray; Midi, Sesame, and Evernow offer broader clinician-selected formularies |
| 6 | You want your own pharmacy | Hers’ published model centers on medication delivered through the program | Wisp, Sesame, Midi, Evernow, or an Alloy prescription transfer |
| 7 | You want live video care | Hers’ public process centers on intake, provider evaluation, messaging, and check-ins | Sesame, Midi, or Evernow |
| 8 | The FTC filed a federal lawsuit | Case No. 3:26-cv-07871 is pending in the Northern District of California | Read the allegations, the company response, and protect your records whether you stay or leave |
Before you pick a provider, check age and state. Winona’s 35–59 rule and 37-state-plus-Puerto-Rico footprint can eliminate it instantly. Midi, Wisp, and Evernow publish nationwide availability, but insurance, product, and prescribing rules still vary.
What did the FTC file against Hims & Hers in July 2026?
Answer: On July 29, 2026, the FTC, California through Los Angeles County Counsel, and Utah sued Hims & Hers Health, Inc. in federal court over alleged subscription enrollment and billing practices, cancellation friction, and sharing sensitive health information with advertising platforms including Meta and Snap. The case is pending; Hims & Hers denies the allegations.
No adjectives from us. Here is the filed record.
| Filing fact | Verified detail |
|---|---|
| Date filed | July 29, 2026 |
| Court | U.S. District Court, Northern District of California |
| Case number | 3:26-cv-07871 |
| Plaintiffs | Federal Trade Commission; California through Los Angeles County Counsel; Utah Division of Consumer Protection |
| Federal laws cited | Section 5 of the FTC Act and the Restore Online Shoppers’ Confidence Act |
| State laws cited | California unfair-competition and false-advertising law; Utah Consumer Sales Practices Act |
| FTC vote | 2–0 |
| Current status | Pending as of August 13, 2026 |
| Primary sources | FTC case page · Filed complaint · Hims & Hers response |
What the complaint alleges
- Intake and first-charge disclosures: the complaint alleges that consumers could be charged and enrolled after submitting an intake, without a clear opportunity to review and affirmatively accept the provider’s treatment recommendation first.
- Recurring refill disclosures: it alleges that refill-charge timing was not disclosed clearly enough for consumers to stop the next charge.
- Cancellation: it alleges that the company failed to provide a simple mechanism to stop recurring charges and that the online path was difficult to locate and complete.
- Sensitive health information: it alleges that information about medical conditions was shared with advertising platforms, including Meta and Snap, despite privacy representations.
What Hims & Hers says
Hims & Hers says the lawsuit disregards evidence supplied during a nearly three-year investigation, ignores established law and industry practice, and “contorts the law to try to manufacture claims.” The company says it will defend itself.
What the lawsuit does not allege
The filed complaint challenges billing, consent, cancellation, and health-data practices across the Hims/Hers platforms. It is not a complaint that Hers menopause medications are counterfeit, that FDA-approved estradiol or progesterone suddenly became unapproved, or that every Hers prescription is clinically improper. That distinction does not erase the allegations. It keeps them accurate.
Six things you can do this week—stay or go
- Download receipts and order history. Save the amount, plan, prescription, and date for every charge.
- Write down the next renewal-processing date. Current Hers terms say subscriptions must be cancelled at least two days before the applicable renewal-processing date. Use the date inside your own account, not a calendar estimate.
- Get your prescription details in writing. Drug, strength, route, quantity, days’ supply, prescriber, and dispensing pharmacy.
- Save what checkout showed you. Screenshot the plan length, monthly equivalent, total due today, renewal cadence, and cancellation language.
- Use the privacy controls. Review the “Your Privacy Choices” link and the Consumer Health Data Privacy Policy. If you believe a charge was unauthorized, the FTC accepts reports at ReportFraud.ftc.gov; your card issuer may also have a dispute deadline.
- Do not create a medication gap to make a point. Symptoms can return after hormone therapy stops. Coordinate the new prescription with a clinician, confirm it can be filled, then cancel the old fulfillment path. Move the prescription first. Then cancel. The order matters.
Subscriptions and analytics are common in telehealth. That is not a reason to ignore the complaint. It is a reason to learn the four numbers every platform should show you before it gets a card: what is due today, what renews, when it renews, and how to stop it.
What does Hers menopause actually cost?
Answer: Hers publishes oral medication from $79 a month and patches from $134 a month, both with a 12-month plan. That produces entry-price equivalents of $237 and $402 over three months, or $948 and $1,608 over 12 months. The exact product, dose, combination, billing schedule, and total charged today must be confirmed at checkout.
Where the price is—and is not
We checked four public Hers pages on August 13, 2026. The original finding is not that Hers has no price. It is that the dollar amount is separated from the main menopause shopping path.
| Hers page checked | Public menopause price found? | What the page showed | Verification date |
|---|---|---|---|
| Menopause storefront | No dollar amount found | Intake, provider evaluation, treatment plan, delivery, messaging | August 13, 2026 |
| Perimenopause page | No dollar amount found | Eligibility and treatment information; service not available in all states | August 13, 2026 |
| Menopause education hub | No dollar amount found | Educational content and links into care | August 13, 2026 |
| Insurance article | Yes | Oral from $79/month; patch from $134/month; both with a 12-month plan | August 13, 2026 |
Three words matter: from, 12-month plan, and confirm at checkout.
Before you pay anyone, write down three separate numbers:
- the advertised monthly equivalent;
- the length of the commitment; and
- the total charged to your card today.
They are not the same number.
What the Hers price buys
The same Hers article puts general retail HRT prices beside its telehealth offer. Its examples include generic oral estradiol around $33 and a generic estradiol patch around $104 at retail pharmacies at the time it published. Those examples are not quotes for your ZIP code, dose, or pharmacy.
That is why “Hers costs $79 but the pill costs $33” is incomplete. The Hers price also covers access to a prescriber, ongoing provider messaging, treatment review, fulfillment, and shipping. Hers is bundling. Whether the bundle is worth it depends on whether you already have those pieces elsewhere.
Primary sources checked August 13, 2026: Hers menopause pricing · Hers menopause storefront · Hers terms and cancellation timing.
How do the 8 Hers alternatives compare side by side?
Answer: The eight replacement paths differ on more than monthly price. The columns that usually decide the answer are insurance for the visit, whether medication is included, pharmacy choice, state and age limits, lab handling, and FDA-approved versus compounded status. The table below uses provider-published facts checked August 13, 2026 and labels anything intake must settle.
| Provider or path | Product category | State availability | Age limit published | Care price | Medication included? | Own pharmacy? | Labs | Insurance |
|---|---|---|---|---|---|---|---|---|
| Hers (benchmark) | Published menopause line uses FDA-approved prescription options; verify exact dispensed product | Says not all states; no complete public list found | No menopause upper limit found | No separate care fee published; oral from $79/month, patch from $134/month with 12-month plan | Yes | Not the published model | Not included as a standard public step | Program is cash-pay |
| Midi Health | Exact product selected by clinician; FDA-approved and compounded status must be checked product by product | All 50 states | No upper limit published | $250 initial; $150 continued-care visit self-pay | No | Yes | Ordered or reviewed when clinically indicated | In-network with most PPOs; plan rules apply |
| Alloy | Published menopause line includes FDA-approved prescription products; confirm exact item | Confirm at intake | 18+ minimum in terms; no upper limit published | $49 consultation; medication priced separately | Yes, when purchased from Alloy | Yes—terms allow transfer | No routine lab bundle published | Cash-pay |
| Winona | FDA-approved patch, tablets, and capsules listed separately from compounded creams | 37 states + Puerto Rico | 35–59 for HRT | Care bundled into product price | Yes | Not the standard model | No routine hormone testing required | Does not bill insurance; HSA/FSA accepted |
| Sesame | Clinician-selected prescription; exact product controls FDA status | Provider availability varies by state and booking | No menopause upper limit published | $59/month | No | Yes | Basic lab work included if necessary; confirm any separate charge at booking | Care is cash-pay; medication may use pharmacy benefits |
| Wisp | Offers access to estradiol patch, gel, oral options and progesterone; verify exact product | All 50 states | Confirm at intake | $99 once for consult, follow-ups, and 3 months of care access | No | Yes | No included-lab promise found on the public menopause page | Care is cash-pay; local drug coverage may apply |
| Evernow | Clinician-selected prescription; product-specific regulatory status | All 50 states + D.C. | No upper limit published | $49 month-to-month; $129/3 months; $420/12 months; or $150 self-pay visit | No | Yes, for eligible prescriptions | Select medications only; case by case otherwise | Commercial insurance for video visits; membership not covered |
| Inner Balance Oestra | Compounded estradiol + progesterone vaginal cream; not FDA-approved | Confirm at intake | Confirm at intake | $199/month first 6 months, then $99.50/month | Yes | Shipped program | Labs optional; dose increases may cost extra | Cash-pay; HSA/FSA eligible |
| Your clinician + pharmacy | Whatever exact product is prescribed | Local/provider dependent | Clinical, not platform, eligibility | Copay, deductible, or cash visit | No | Yes | As clinically indicated | Depends on plan |
Two columns deserve more attention than they usually get.
Upper age limit: Winona’s rule is a company eligibility rule, not a medical verdict that women 60 and older cannot use hormone therapy. The Menopause Society says hormone therapy does not need to be routinely discontinued after 60 or 65 and can be continued for selected women after individualized evaluation.
State list: Midi, Wisp, and Evernow publish nationwide availability. Winona publishes its exact list. Hers says it is not in every state without publishing the full list on the pages checked. Alloy, Sesame, and Inner Balance should be confirmed during intake because product and clinician availability can change by state.
Provider sources checked August 13, 2026: Midi pricing, insurance, eligibility, and nationwide access · Alloy patch pricing and terms · Winona eligibility and product prices · Sesame menopause program · Wisp menopause consult · Evernow pricing, insurance, pharmacy, labs, and access · Oestra treatment and pricing.
Which Hers alternatives take insurance?
Answer: Midi and Evernow are the clearest insurance paths for the clinical visit. Midi is in-network with most PPO plans; Evernow says video visits can use major commercial plans. Sesame, Wisp, Alloy, Winona, Hers, and Oestra are cash-pay care models, although a prescription sent to your own pharmacy may still run through your drug benefit.
“Does it take insurance?” is three questions, not one:
- Is the clinician visit in-network?
- Is the exact medication on your plan’s formulary?
- Is the dispensing pharmacy in-network?
You can get a yes on one and a no on the other two.
| Provider | Visit can be billed to insurance? | Medication can use your pharmacy benefit? | Critical limitation |
|---|---|---|---|
| Hers | No published insurance billing for the menopause program | Not the standard published model | Cash-pay bundle |
| Midi | Yes—most PPO plans; verify yours | Yes, through your pharmacy | Cannot treat Medicaid or Medi-Cal patients even as self-pay; Medicare beneficiaries may self-pay but cannot submit Midi claims |
| Alloy | No | Yes, if the prescription is transferred | Transfer and local price must be confirmed before cancelling shipment |
| Winona | No direct insurance billing | Not the standard model | Entry prices and 28-day cadence; possible reimbursement is not guaranteed |
| Sesame | Care is cash-pay | Yes | Medication is separate; confirm any separate lab charge at booking |
| Wisp | Care is cash-pay | Yes | Pharmacy price is separate from the $99 care charge |
| Evernow | Commercial insurance for video visits | Yes for most local-pharmacy prescriptions | Membership fees are not insurance-covered; Medicare and Medicaid coverage are not supported |
| Oestra | No | Not the program model | Compounded medication is typically outside standard formulary coverage |
The damaging admission about Midi
Midi is the strongest insurance path on this page, and The HRT Index may earn a commission from a Midi link. So here is the flaw before the pitch.
Midi does not give you one predictable all-in medication price. If that is your priority, Alloy, Winona, or staying with Hers is a better fit. Midi charges for care, then your pharmacy charges for the medication. Deductibles, coinsurance, copays, drug tiers, prior authorization, and pharmacy networks can all change the total.
But because Midi separates the clinician from the fulfillment subscription, it can give you something Hers does not center: your prescription at your pharmacy, with your drug benefit available. Cancelling future care does not erase medication already dispensed, although future refills still require a valid prescription and clinician authorization.
Midi also cannot treat Medicaid or Medi-Cal patients even if they offer to self-pay. It is not covered by Medicare or Medicare-related plans, though Medicare beneficiaries may use Midi as self-pay and cannot submit Midi-related claims.
If you want insurance-eligible menopause care and a prescription sent to your pharmacy, check whether Midi is in-network for your plan → (sponsored link)
Primary sources: Midi costs, commercial insurance, Medicare, and Medicaid/Medi-Cal policy · Evernow insurance, membership, local-pharmacy, and lab policy · Alloy prescription-transfer and cancellation terms.
Which provider will actually treat me in my state and age range?
Answer: Midi and Wisp publish all-50-state availability, and Evernow publishes all 50 states plus D.C. Winona publishes 37 states plus Puerto Rico and limits HRT to ages 35–59. Hers says it is not available in every state but does not publish a full list on the checked menopause pages. All clinical eligibility remains individualized.
Winona currently serves:
Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, Washington, Wisconsin, Wyoming, and Puerto Rico.
That leaves these 13 states plus D.C. outside Winona’s published HRT footprint:
Alabama, Alaska, Arkansas, Kansas, Louisiana, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota, Utah, Vermont, West Virginia, and Washington, D.C.
Do not turn a platform rule into a judgment about your body. Winona drawing a line at 59 does not mean 60-year-olds are automatically ineligible for hormone therapy. It means Winona does not initiate HRT for them. Midi, Evernow, Wisp, Sesame, Alloy, your insurer, or an in-person clinician may have different intake rules.
Primary sources: Winona state and age eligibility · Midi nationwide care · Wisp nationwide availability · Evernow nationwide availability · The Menopause Society on individualized duration beyond age 60 or 65.
Is Hers FDA-approved—and are the alternatives?
Answer: FDA approval belongs to the exact finished drug, not to the telehealth logo. Hers’ published menopause offering includes FDA-approved prescription options. Alloy, Midi, Sesame, Wisp, Evernow, and Winona can provide FDA-approved products, but Winona also sells compounded creams. Inner Balance Oestra is compounded and the final cream is not FDA-approved.
A company is not a regulatory category. The product is.
- FDA-approved means the exact finished product completed FDA review for its approved use, manufacturing quality, and labeling.
- Compounded means a pharmacy prepared a drug for an individual patient or permitted supply pathway. The FDA does not verify a compounded drug’s safety, effectiveness, or quality before marketing.
The word bioidentical does not settle that question. FDA-approved estradiol and micronized progesterone products can be described as bioidentical. Compounded hormones may also be marketed with that word. It tells you nothing by itself about whether the finished bottle, cream, capsule, or patch went through FDA approval.
The FDA states that compounded drugs are not FDA-approved. ACOG says compounded bioidentical menopausal hormone therapy should not be routinely prescribed when FDA-approved formulations exist. The Menopause Society says custom-compounded hormones have not been shown to be safer or more effective than approved products.
The Winona contradiction—and the NDC correction
Winona’s live product pages label its estrogen patch, estrogen tablets, and progesterone capsules as FDA-approved. Its body creams say the final medication is compounded, even when ingredients are used in other FDA-approved drugs. Elsewhere, Winona’s FAQ has described its HRT options more broadly as compounded. That is enough conflict to justify one question before payment:
“What exact product name, manufacturer, dosage form, and strength will be dispensed, and does that finished product appear in Drugs@FDA?”
Do not rely on an NDC number alone. The FDA says assignment of an NDC does not denote approval, and implying otherwise is misleading.
A compounded cream is not a dose-for-dose patch replacement
A 2023 retrospective cohort study in Menopause compared laboratory estrogen exposure among women using compounded transdermal estradiol creams and FDA-approved patches or gels. At similar labeled dose ranges, the compounded creams were associated with lower estrogen exposure. The study does not prove every compounded cream will behave the same way, but it is enough to reject casual “just swap the patch for a cream” math.
Your new clinician should decide the route and dose. A comparison page should not.
Primary medical and regulatory sources: FDA compounding Q&A · FDA National Drug Code Directory warning · ACOG Clinical Consensus No. 6 · The Menopause Society on custom-compounded hormones · Newman et al., 2023.
What if Hers does not carry the medication form I want?
Answer: Hers publicly lists estradiol pill or patch, progesterone pill, and estradiol vaginal cream. It does not publicly list every systemic or local form. Alloy publishes gel and spray; Midi, Sesame, and Evernow offer broader clinician-selected formularies; and Bijuva is an FDA-approved oral estradiol-progesterone capsule. Match the route before comparing the brand.
People compare companies. You should compare the thing in your hand.
| Current or wanted form | Paths that publish or may prescribe it | What is not an equal swap |
|---|---|---|
| Oral estradiol | Hers, Midi, Sesame, Alloy, Wisp, Evernow, Winona | A compounded body cream is not a dose-for-dose tablet replacement |
| Estradiol patch | Hers, Midi, Sesame, Alloy, Wisp, Evernow, Winona | A compounded cream is not a dose-for-dose patch replacement |
| Oral micronized progesterone | Hers, Midi, Sesame, Alloy, Wisp, Evernow, Winona | Medroxyprogesterone acetate is a different progestogen; confirm the exact product |
| Estradiol vaginal cream | Hers, Midi, Sesame, Alloy, Evernow; Winona lists vaginal estrogen cream | Systemic estrogen does not automatically replace local vaginal therapy, and local therapy does not automatically replace systemic therapy |
| Gel or spray | Alloy; clinician-selected options through Midi, Sesame, or Evernow | Different routes can have different doses and absorption |
| Vaginal ring | Midi, Sesame, Evernow, or your clinician—confirm at intake | Estring and Femring are not the same type of estrogen exposure or indication |
| Combined estradiol + progesterone oral capsule | Bijuva through a willing clinician | A compounded combined body or vaginal cream is a different finished drug and route |
| Testosterone | A clinician who can lawfully and appropriately prescribe it | Testosterone is a Schedule III controlled substance, requires a prescription, and no testosterone product is FDA-approved for women in the United States |
Oestra does not contain testosterone. Inner Balance says progesterone can participate in the body’s hormone pathways and markets “testosterone via conversion.” That is not testosterone medication, not a testosterone prescription, and not a substitute for a clinician deciding that testosterone is appropriate.
Safety flag: unexplained bleeding after menopause needs clinical evaluation before you start or change systemic hormone therapy. This is one of the situations where an online-only intake may not be the right starting point.
Product and regulatory sources: Hers menopause options · Alloy estradiol gel and Evamist spray · Bijuva prescribing information · 21 CFR § 1308.13, Schedule III.
Is there still an estradiol patch shortage?
Answer: Some estradiol patch products remain manufacturer- and strength-specific constraints, but “all patches are unavailable” is false. The American Society of Health-System Pharmacists’ August 7, 2026 bulletin lists several products on back order or allocation and others available. Confirm your exact strength and manufacturer before cancelling a supply chain that is working.
The practical risk is not “there are no patches.” It is that your exact patch may be unavailable at your exact pharmacy while another manufacturer or strength remains available.
The ASHP bulletin lists a mixture of statuses across Sandoz, Dotti, Viatris/Mylan, Noven, and Zydus products. Some presentations are available; others are allocated or back-ordered. These statuses move.
Three things follow:
- Shortage is strength-specific and manufacturer-specific. “Estradiol patch” is not one inventory item.
- Shipped telehealth fulfillment and a retail pharmacy are different supply chains. Reliability today is a real decision factor.
- Ask before cancelling: “Can you fill my exact strength now, and which manufacturer will you dispense?”
Never change dose, frequency, or route because a comparison table says another box is easier to find. That is a prescribing decision. See the estradiol patch dosage guide for an explanation of how patch strengths are labeled—not instructions to change your dose.
Primary inventory source checked August 13, 2026: ASHP Drug Shortage Detail—Estradiol Transdermal System, updated August 7, 2026.
What will each Hers alternative cost in 90 days and in a year?
Answer: At published entry prices, Alloy’s pill-plus-progesterone path is $237.97 for the first 90 days and $804.88 in year one, while Winona’s patch-plus-progesterone path is $564 for three 28-day cycles and $2,444 for thirteen cycles. Insurance-based and local-pharmacy paths cannot be responsibly totaled without your plan, drug, dose, and pharmacy.
Illustrative published-price arithmetic—not a quote. “Entry price” means the lowest price the provider publishes; higher strengths, doses, products, visits, labs, or fees may change the total. Confirm the amount charged today at checkout.
| Path | What the number includes | First 90 days or closest published cycle | First year or closest published annual cycle |
|---|---|---|---|
| Hers oral | Care + shipped medication at published entry price | $237 | $948 |
| Hers patch | Care + shipped medication at published entry price | $402 | $1,608 |
| Alloy pill + progesterone | $49 consult + $39.99/month pill + $23/month progesterone | $237.97 | $804.88 |
| Alloy patch + progesterone | $49 consult + $74.99/month patch + $23/month progesterone | $342.97 | $1,224.88 |
| Winona tablets + progesterone capsules | $54 + $39 per 28-day cycle at entry prices | $279 for 84 days | $1,209 for 364 days |
| Winona patch + progesterone capsules | $149 + $39 per 28-day cycle at entry prices | $564 for 84 days | $2,444 for 364 days |
| Sesame standard program | Care and basic labs if necessary; medication extra | $177 care only | $708 care only |
| Wisp | Consult, follow-ups, and three months of care-team access; medication extra | $99 care only | Cannot be settled from the public page after month 3 |
| Evernow membership | Membership; visits and medication may be separate | $129 membership | $420 membership |
| Evernow pay-per-visit | One self-pay video visit and 90-day portal access; medication extra | $150 + medication | Depends on visit frequency |
| Midi self-pay | $250 initial visit; $150 each continued-care visit; medication extra | Depends on number of visits | Cannot be responsibly annualized without follow-up cadence |
| Midi insured | Plan cost-sharing + medication | Plan-specific | Plan-specific |
| Oestra | Compounded cream, shipping, and follow-up; dose increases may cost extra | $597 | $1,791 |
| Your clinician + pharmacy | Visit + exact medication | Plan, clinician, and pharmacy-specific | Plan, clinician, and pharmacy-specific |
The original cost insight is not a “cheapest provider” badge. It is the billing-normalization rule:
- Hers and Alloy use calendar-month arithmetic.
- Winona’s 30-day supplies process every 28 days, producing thirteen charges over 364 days.
- Sesame, Wisp, Evernow, and Midi can be care-only prices with medication separate.
- Oestra steps down after six months, so multiplying $199 by twelve is wrong.
For more medication-versus-care arithmetic, see the 2026 HRT cost guide.
Pricing inputs checked August 13, 2026: Hers · Alloy patch and progesterone · Winona products and billing cadence · Sesame · Wisp · Evernow · Midi · Oestra.
Want video care, provider choice, basic labs when necessary, and a local pharmacy? See Sesame’s current $59 menopause program before booking → (sponsored link)
Are Alloy and Wisp the lowest-commitment cash-pay paths?
Answer: Alloy is the lowest published first-year shipped pill-plus-progesterone calculation in this comparison at $804.88 using entry prices. Wisp has the lowest published initial care charge at $99, but medication is separate and its public page does not settle care costs after three months. The HRT Index earns nothing from either company on this page.
Alloy
Alloy charges a $49 consultation fee, then publishes menopause medication prices by product: estradiol pill from $39.99/month, patch from $74.99/month, progesterone from $23/month, and estradiol gel or Evamist spray at $69.99/month. Products ship after a clinician recommends and the patient confirms a plan.
The honest catch is buried in two different clocks:
- Alloy’s current terms say cancel the subscription seven days before the end of the current subscription period.
- Shipment cancellation or pause requests must be made five business days before the next shipment processes.
The terms also say consultation and service fees are nonrefundable, product refunds are limited to the first shipment of each product, and qualifying requests must be made within 30 days of receipt. Put both cancellation deadlines in your calendar.
Alloy’s terms allow a prescription transfer to a pharmacy of your choice. Do not cancel Alloy fulfillment until the receiving pharmacy confirms it has the prescription and can fill the exact drug.
Wisp
Wisp charges $99 once for the menopause consult, follow-ups, and three months of access to the care team. If prescribed, the medication goes to a local pharmacy and is paid separately. Wisp publishes availability in all 50 states and says treatment can be sent to the pharmacy the same day when prescribed.
The honest catch is not “Wisp never orders labs”—the public menopause page does not support that categorical claim. The accurate version is narrower: the $99 page does not promise an included lab package. Ask whether your clinician needs testing, where it will be ordered, and who pays.
Wisp is strongest when you already know the route you need, want a local pharmacy, and do not want a monthly care subscription. It is weaker when you need broad diagnostic work, complex risk evaluation, or a relationship that clearly continues after the first three months.
Primary sources: Alloy patch pricing and consultation fee · Alloy progesterone pricing · Alloy transfer, refund, and cancellation terms · Wisp consult price, included care, pharmacy model, and nationwide availability.
Is Sesame or Evernow a better video-care alternative?
Answer: Sesame is the cleaner $59 monthly cash-pay video program, with a provider you choose, ongoing care, and basic labs if necessary; medication is separate. Evernow gives you more payment models: $150 pay-per-visit, $49 month-to-month membership, $129 for three months, or $420 for a year, with commercial insurance available for video visits.
Sesame
Sesame’s live menopause page publishes $59/month. The program includes video care, provider choice, ongoing messaging, and basic labs when necessary. Medication is sent to a preferred pharmacy and is not included in the subscription price.
The lab boundary matters. Sesame’s public menopause page says basic lab work is included if necessary; it does not make every possible test or outside service part of the $59 price. Confirm any separate lab charge on the booking screen.
Sesame is the better fit when you want a real video relationship, cash-pay clarity, and local-pharmacy control. It is not the best fit when you want the medication included in one shipped number.
Evernow
Evernow is available in all 50 states plus D.C. Its pay-per-visit model costs $150 self-pay and provides a video consult plus 90-day access to prescriptions and the care portal. Its membership costs $49 month-to-month, $129 for three months, or $420 for 12 months, with secure messaging and optional video visits.
Commercial insurance can cover video visits depending on eligibility and plan. Membership fees are not covered. Most local-pharmacy prescriptions can use commercial insurance or discounts; some products must go through partner pharmacies and remain cash-pay. Labs are required for select medications and offered case by case otherwise.
Evernow is the best fit here when you want to choose between a one-time consult and ongoing membership without losing nationwide access. The trap is assuming the $35 annual-plan equivalent includes the visit and medication. It does not automatically do either.
Primary sources checked August 13, 2026: Sesame menopause program · Evernow FAQ.
Is Winona a better fit than Hers?
Answer: Winona is the closest shipped-bundle alternative when you liked Hers’ medication-included model but want to avoid Hers’ 12-month advertised-price condition. It is limited to women ages 35–59 in 37 states plus Puerto Rico, and 30-day prescriptions process every 28 days. Its FDA-approved patch, tablets, and capsules must remain separate from its compounded creams.
Winona wins on one thing Hers customers often want to preserve: the medication arrives and the care is built into the product price.
| Winona product | Published entry price | Regulatory category published by Winona | Billing effect |
|---|---|---|---|
| Estrogen tablets | $54 per 28-day cycle | FDA-approved | 13 entry-price charges = $702 over 364 days |
| Progesterone capsules | $39 per 28-day cycle | FDA-approved | 13 entry-price charges = $507 over 364 days |
| Estrogen patch | $149 per 28-day cycle | FDA-approved | 13 entry-price charges = $1,937 over 364 days |
| Estrogen body cream | $89 per 28-day cycle | Compounded final medication | Do not present as FDA-approved because ingredients appear in approved drugs |
| Estrogen + progesterone body cream | $89 per 28-day cycle | Compounded final medication | Route and endometrial-protection evidence require clinician scrutiny |
| Vaginal estrogen cream | From $89 | Confirm exact dispensed product | Requested as needed rather than automatic refill, according to the FAQ |
Three checks before you pay:
- Age: Winona only offers HRT treatment plans to women 35–59.
- State: confirm you are in one of the 37 published states or Puerto Rico.
- Exact finished product: ask for product name, manufacturer, route, strength, and approval status. An NDC alone does not prove approval.
Winona’s 30-day supplies process every 28 days, and its 90-day supplies process every 84 days. There is a 24-hour order-cancellation window after processing begins; after that, orders cannot be cancelled, refunded, or returned. That billing cadence is why twelve-times-monthly math understates a year.
If you are 35–59, live in a served state, and want medication included in one shipped price, check Winona’s current eligibility and treatment options → (sponsored link)
Looking for a company-specific exit page instead? See Winona HRT alternatives or Wisp menopause alternatives.
Primary sources checked August 13, 2026: Winona products and entry prices · Winona eligibility, refill cadence, and cancellation rules · Winona’s FDA-approved-versus-compounded product statement · FDA warning that an NDC does not denote approval.
Is Inner Balance Oestra a real replacement for Hers?
Answer: Oestra is a compounded vaginal cream containing estradiol and progesterone, priced at $199/month for six months and $99.50/month after that. The final drug is not FDA-approved. It is not a like-for-like replacement for an FDA-approved Hers patch, tablet, or progesterone capsule; it is a deliberate move into a compounded route requiring product-specific clinical scrutiny.
We are fencing this section off on purpose.
If you are leaving a Hers regimen made from FDA-approved products, you are already in the approved-product lane. Moving to Oestra is not just changing companies. It changes the finished drug, route, evidence base, pharmacy pathway, and regulatory status.
What Inner Balance currently publishes
- Oestra combines estradiol and progesterone in one daily vaginal cream.
- Price is $199/month for the first six months, then $99.50/month.
- Shipping and follow-up are included; dose adjustments may cost extra.
- Labs are optional.
- The page describes a 503A U.S. pharmacy, while other current Inner Balance treatment pages describe Oestra as made by a 503B pharmacy.
- Oestra does not contain testosterone, despite marketing language about progesterone and “testosterone via conversion.”
That 503A/503B conflict is not decoration. Those are different statutory compounding pathways. Ask Inner Balance to identify the dispensing pharmacy and its status in writing for your prescription.
The regulatory line
Inner Balance may state that ingredients are sourced from FDA-inspected manufacturers or used in FDA-approved products. That does not make the final compounded cream FDA-approved. The FDA says compounded drugs are not premarket-reviewed for safety, effectiveness, or quality.
The uterine-lining question
If you have a uterus and use systemic estrogen, endometrial protection is not a footnote. Ask:
“What evidence supports this progesterone route and dose for protecting my uterine lining with this systemic estrogen exposure, and how will you monitor me?”
A 2021 analysis from the ELITE trial evaluated a specific regimen of oral estradiol with intermittent vaginal progesterone gel and found that regimen did not completely oppose estrogen’s effects on the endometrium. That study did not test Oestra and does not prove Oestra fails. It proves that vaginal progesterone cannot be assumed to provide adequate protection simply because progesterone is present.
The Menopause Society warns that custom-compounded products may not provide predictable hormone levels. That is why the exact route and dose matter more than “all-in-one” convenience.
Not what you were looking for? See the FDA-approved-only paths in Find My HRT Path →
Primary sources: Oestra treatment, contents, and step-down pricing · Inner Balance FAQ describing a 503A pharmacy · Inner Balance product page describing a 503B pharmacy · FDA compounding Q&A · The Menopause Society · ELITE endometrial analysis.
Is using my own clinician and pharmacy the better Hers alternative?
Answer: Your own clinician and pharmacy can be the lowest-friction path when you already have a prescriber, need in-person evaluation, use Medicare or Medicaid coverage, or want full control over manufacturer and pharmacy. It is not automatically cheaper or faster: appointment access, follow-up, prior authorization, and local inventory can become the new bottlenecks.
This is the ninth row hiding inside an eight-provider article because it is not a company.
Your clinician plus pharmacy wins when:
- you need an examination, imaging, biopsy, or complex risk evaluation;
- your insurer requires an in-network clinician or prior authorization;
- you want a specific generic manufacturer or brand;
- you are on Medicaid or Medicare and need covered care;
- you already have a clinician who will continue the exact regimen;
- you need coordinated care with oncology, cardiology, gynecology, or primary care.
It loses when the next available appointment is months away, nobody will own the prescription, or every dose change starts a new scheduling battle. Telehealth exists because those failures are real.
A local prescription is not automatically continuity. Before leaving Hers, get a named clinician to confirm that they will prescribe, a pharmacy to confirm that it can fill, and a date for the first follow-up.
How do I switch from Hers without a gap in my prescription?
Answer: Start the new clinical process before cancelling the old fulfillment path. Collect your current drug, strength, route, quantity, days’ supply, prescriber, pharmacy, and next renewal date; then confirm the new prescription is written and fillable. Cancel only after the receiving pharmacy or new shipment has confirmed the medication—not merely after you submit an intake.
Nothing else on this page matters if you run out in week two. Do it in this order.
1. Find the next renewal-processing date
Open your Hers account and write down the date attached to each active menopause order or plan. Current general terms say cancellation must occur at least two days before the applicable renewal-processing date. Give yourself more room than the minimum.
2. Photograph and record the exact regimen
Save:
- drug name;
- strength;
- dosage form;
- directions;
- quantity;
- days’ supply;
- manufacturer if a patch or product switch matters;
- prescriber;
- dispensing pharmacy;
- last fill date; and
- refills remaining, if shown.
3. Start the new provider before cancelling Hers
An intake form is not a prescription. A treatment recommendation is not a filled prescription. A prescription sent is not a prescription in stock.
Overlap the administrative process on purpose.
4. Ask one transfer question
“Can you continue my exact current regimen, or are you proposing a change?”
A change in strength, route, molecule, or progesterone plan is a clinical change. Make sure it is intentional—not the accidental result of a platform’s smaller formulary.
5. Confirm supply
For a patch, ask the exact strength and manufacturer. For a local pharmacy, ask when it will be ready. For shipped medication, ask when it has actually left the pharmacy—not when the care plan was approved.
6. Cancel after the replacement is real
Screenshot the cancellation confirmation and the effective date. Then watch the next card statement and account status.
7. Keep the clinical follow-up
A successful transfer is not only possession of the next box. It is knowing who handles side effects, bleeding, dose questions, refill authorization, and the next review.
The 12 questions to ask before you pay anyone
These are grouped by the five things The HRT Index evaluates.
Clinical legitimacy
- What exact finished product will be prescribed, and is it FDA-approved or compounded?
- Which pharmacy will dispense it?
Care quality
- Is there a live video visit, messaging only, or both?
- Who responds after the prescription, how quickly, and will it be the same clinician?
Medication fit
- Can you continue my current route and strength, or are you proposing a change?
- If I have a uterus and use systemic estrogen, what is the endometrial-protection plan?
Price transparency
- What exact amount is charged today?
- Is the displayed monthly price tied to a three-, six-, or 12-month plan?
- When will the next charge process?
- Is medication included, billed by another pharmacy, or subject to dose-based pricing?
Access
- Do you serve my state and age group, and will my insurance apply to the visit, drug, and pharmacy?
- Can the prescription go to my own pharmacy, and what happens to refills if I cancel care?
Build my matched shortlist and switching checklist →
What if I want to stay with Hers and just fix the billing and privacy?
Answer: Staying is a legitimate decision when your regimen works, supply is reliable, and the charges match the agreement. The FTC complaint does not require every patient to leave. It gives you a reason to document the plan, renewal date, prescription, privacy choices, and cancellation route instead of trusting that you will remember them later.
Nothing on this page requires you to leave.
If symptoms are controlled, your medication form fits, and the total is acceptable, then the thing you are shopping for may not be a new provider. It may be control.
Do the six recordkeeping steps in the FTC section. Set a reminder before renewal. Save the screenshots. Keep your prescription details outside the app. Review the privacy controls. Know which clinician or pharmacy becomes the backup if supply fails.
Then go live your life. That is a completely reasonable outcome from a comparison page, and any page unwilling to say it is selling you something.
Hers menopause care (editorial link; The HRT Index earns nothing from this link on this page)
How did The HRT Index verify this comparison?
Answer: The HRT Index Verification Standard checks the commercial fact that can change, the regulatory status of the exact product, and the decision consequence for the reader. Top providers are rechecked monthly and the full roster quarterly. Conclusions are conditional—based on insurance, medication route, state, age, and pharmacy—not converted into a fake numeric score.
We evaluate every provider on five pillars, always in this order:
- Clinical legitimacy — who prescribes, which pharmacy dispenses, and the regulatory status of the exact finished product.
- Care quality — visit format, follow-up, continuity, responsiveness, and referral when online care is not enough.
- Medication fit — systemic versus local therapy, available routes, product identity, and strict separation of FDA-approved and compounded options.
- Price transparency — consultation, care, medication, labs, plan length, billing cadence, renewal, cancellation, and checkout-only charges.
- Access — state, age, insurance, pharmacy choice, labs, and eligibility restrictions.
We do not assign stars, points, or provider scores. A number would hide the fact that a woman with Medicaid, a woman over 60, a woman who needs a vaginal ring, and a woman who wants a shipped cash-pay patch are not making the same decision.
Provider-stated versus independently verified
| Claim type | How this page handles it | Example |
|---|---|---|
| Provider-published commercial fact | Link, date, and reproduce only what the live page supports | Evernow: all 50 states plus D.C.; $49 / $129 / $420 membership options |
| Government or regulatory fact | Primary agency or regulation | FTC case status; FDA compounded-drug status; testosterone Schedule III |
| Medical guidance | The Menopause Society, ACOG, FDA labeling, or peer-reviewed literature | Endometrial protection; compounded-product cautions; patch-versus-cream exposure |
| Provider marketing claim | Attribute it and do not upgrade it into independent proof | Inner Balance’s claims about testing or absorption |
| Checkout-dependent fact | Label confirm at checkout | Exact dose price, state eligibility, amount due today, pharmacy inventory |
| Editorial conclusion | Tie it directly to verified facts | Midi is the strongest insurance path; Wisp is the lowest published initial care charge |
Who: The HRT Index Editorial Team. How: primary-source commercial verification, regulatory documents, published medical guidance, and arithmetic shown on the page. Why: so women can choose the right starting path before a consult without an affiliate payment quietly choosing it for them.
Found an error? Send a correction. Prices, policies, formularies, and state rules move; corrections should carry a date.
Frequently asked questions
How much does Hers menopause cost?
Hers publishes oral medication from $79 a month and patches from $134 a month, both with a 12-month plan. At those entry prices, the 12-month equivalents are $948 and $1,608. Confirm the exact medication, dose, plan length, billing cadence, and amount charged today at checkout.
Is Hers being sued?
Yes. On July 29, 2026, the FTC, California through Los Angeles County Counsel, and Utah filed a federal complaint against Hims & Hers Health, Inc. over alleged billing, cancellation, and sensitive-health-data practices. The case is pending, Hims & Hers denies the allegations, and no court has ruled.
Is Hers menopause HRT FDA-approved?
Hers’ published menopause offering includes FDA-approved prescription options such as estradiol and progesterone. Approval applies to the exact finished product dispensed, not the telehealth brand. Ask for the product name, manufacturer, dosage form, and strength. Hormone therapy is not FDA-approved specifically for “perimenopause” as a condition, so some prescribing during perimenopause may be off-label.
Does Hers take insurance for menopause care?
Hers markets its menopause program as cash-pay access without insurance. Midi and Evernow are the clearest alternatives for insurance-eligible visits. A prescription sent to your local pharmacy through Midi, Evernow, Sesame, Wisp, or an Alloy transfer may use your drug benefit if the medication and pharmacy are covered.
What states is Hers menopause available in?
Hers says menopause treatment is not available in every state but did not publish a complete state list on the public menopause pages we checked August 13, 2026. Intake is the current availability check. Midi and Wisp publish all 50 states; Evernow publishes all 50 plus D.C.; Winona publishes 37 states plus Puerto Rico.
How do I cancel Hers?
Use the in-app or online-account subscription controls or contact the Help Center. Current general Hers terms say cancellation must occur at least two days before the applicable renewal-processing date. Use the date inside your account, save the confirmation, and verify every active menopause order or plan shows the expected status.
Can I keep my prescription if I cancel?
Cancelling a shipped subscription stops future fulfillment under that program; it does not guarantee another clinician or pharmacy will continue the regimen. The safest move is to secure a new prescriber, have the prescription written, and confirm the pharmacy or shipment can fill it before cancellation.
Is Midi or Winona better than Hers?
Midi is better when commercial insurance, broader clinical care, and your own pharmacy matter most. Winona is closer to Hers when you want medication included and shipped, but Winona restricts HRT to ages 35–59 and 37 states plus Puerto Rico. Hers may remain the better-value oral bundle when it works and the plan is acceptable.
Do any of these bill Medicaid?
None of the compared telehealth programs publishes Medicaid billing as its standard menopause-care model. Midi goes further: it says it cannot treat Medicaid or Medi-Cal patients even if they offer to self-pay. Evernow does not support Medicare or Medicaid coverage. Start with your plan’s directory, a covered gynecology or primary-care clinic, a community health center, or The Menopause Society’s practitioner directory.
Is there a Hers alternative without a 12-month plan?
Yes. Wisp charges $99 once for the consult and three months of care access. Midi charges per visit. Evernow offers pay-per-visit, month-to-month, three-month, and annual options. Sesame is $59 monthly. Alloy bills medication on its subscription cadence, with separate seven-day subscription and five-business-day shipment cutoffs.
Does Hers prescribe testosterone for menopause?
Hers does not publicly list testosterone in its menopause offering. Testosterone is a Schedule III controlled substance in the United States, requires a prescription, and no testosterone product is FDA-approved for women. Any telehealth option must comply with federal and state controlled-substance rules and make an individualized prescribing decision.
Is compounded hormone therapy the same as FDA-approved hormone therapy?
No. Compounded drugs are not FDA-approved, and the FDA does not verify their safety, effectiveness, or quality before marketing. “Bioidentical” does not mean “FDA-approved.” ACOG and The Menopause Society recommend FDA-approved options when they can meet the patient’s needs rather than routinely using compounded hormone therapy.
Why is Winona’s annual cost based on 13 charges?
Winona says 30-day prescriptions are processed every 28 days. Thirteen 28-day cycles equal 364 days, so multiplying the displayed price by 12 understates the closest full-year cost by one charge. Its 90-day supplies process every 84 days.
Is Oestra FDA-approved?
No. Oestra is a compounded estradiol-and-progesterone vaginal cream. Ingredients may appear in FDA-approved drugs, and a pharmacy may follow a lawful compounding pathway, but the final Oestra product is not FDA-approved. Ask for the dispensing pharmacy, 503A or 503B status, exact dose, monitoring plan, and evidence for the progesterone route if you have a uterus.
I meant alternatives to hormone therapy, not alternatives to Hers. Where do I go?
See nonhormonal options for menopause symptoms. That page covers prescription and nonprescription paths without turning supplements into substitutes for evidence-based care.
Still not sure which HRT program is right for you?
A general comparison cannot account for your state, insurance, age, whether you have a uterus, risk history, pharmacy benefit, and the exact form you are taking. Those details change the answer.
Take The HRT Index's free Find My HRT Path quiz.
It narrows the providers that fit your situation, separates FDA-approved from compounded paths, and flags when online care is not the right starting point.
Educational content only. This is not medical advice and is not a substitute for care from a licensed clinician. Do not start, stop, or change hormone therapy based on this page. Prices, availability, formularies, insurance, pharmacy inventory, and policies change. Top providers are rechecked monthly and the full roster quarterly under The HRT Index Verification Standard. Editorial standards · Corrections · Affiliate disclosure